Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population—on behalf of the Italian Research Group for Gastric Cancer
Advanced gastric cancer; Gastrectomy; Laparoscopy; Minimally invasive surgery; Survival; Humans; Propensity Score; Retrospective Studies; Treatment Outcome; Gastrectomy; Stomach Neoplasms; Adenocarcinoma; Laparoscopy
Advanced gastric cancer
Survival
Advanced gastric cancer; Gastrectomy; Laparoscopy; Minimally invasive surgery; Survival
610
Adenocarcinoma
Advanced gastric cancer; Gastrectomy; Laparoscopy; Minimally invasive surgery; Survival;
03 medical and health sciences
Treatment Outcome
0302 clinical medicine
Retrospective Studie
Stomach Neoplasm
Minimally invasive surgery
Stomach Neoplasms
Gastrectomy
617
Humans
Laparoscopy
Propensity Score
Human
Retrospective Studies
DOI:
10.1007/s10120-022-01321-w
Publication Date:
2022-07-21T16:04:45Z
AUTHORS (49)
ABSTRACT
Oncologic outcomes after laparoscopic gastrectomy for advanced gastric cancer in the West have been poorly investigated. The aim of the present study was to compare survival outcomes in patients undergoing curative-intent laparoscopic and open gastrectomy for advanced gastric cancer in several centres belonging to the Italian Research Group for Gastric Cancer.Data of patients operated between 2015 and 2018 were retrospectively analysed. Propensity Score Matching was performed to balance baseline characteristics of patients undergoing laparoscopic and open gastrectomy. The primary endpoint was 3-year overall survival. Secondary endpoints were 3-year disease-free survival and short-term outcomes. Multivariable regression analyses for survival were conducted.Data were retrieved from 20 centres. Of the 717 patients included, 438 patients were correctly matched, 219 per group. The 3-year overall survival was 73.6% and 68.7% in the laparoscopic and open group, respectively (p = 0.40). When compared with open gastrectomy, laparoscopic gastrectomy showed comparable 3-year disease-free survival (62.8%, vs 58.9%, p = 0.40), higher rate of return to intended oncologic treatment (56.9% vs 40.2%, p = 0.001), similar 30-day morbidity/mortality. Prognostic factors for survival were ASA Score ≥ 3, age-adjusted Charlson Comorbidity Index ≥ 5, lymph node ratio ≥ 0.15, p/ypTNM Stage III and return to intended oncologic treatment.Laparoscopic gastrectomy for advanced gastric cancer offers similar rates of survival when compared to open gastrectomy, with higher rates of return to intended oncologic treatment. ASA score, age-adjusted Charlson Comorbidity Index, lymph node ratio, return to intended oncologic treatment and p/ypTNM Stage, but not surgical approach, are prognostic factors for survival.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (54)
CITATIONS (12)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....